Plot Twist: 80% of Clinical Trials DO NOT Miss Enrollment Timelines Because of Poor Recruitment
It’s one of the most well-documented problems in clinical research, yet year after year, it...
Featured contributor to the SCRS initiative reducing redundant site training by 25%+
The Patient Perspective in Oncology Research Participation
It’s one of the most well-documented problems in clinical research, yet year after year, it...
Screen failures in clinical research are a necessary, unpredictable, and disruptive part of the...
Over the past year, ProofPilot truly leveled up—we generated amazing customer experiences, joined...
ProofPilot’s acquisition of Lokavant will have a strong, direct impact on clinical trial...
It’s a familiar story in clinical research: a referral comes through, the patient looks like a...
In a recent interview with The Clinical Trial Vanguard, our Chief Strategy Officer, Joseph Kim...
If you missed DPharm 2024, you also missed watching a live matchmaking event with Nichole Gallatti,...
In a throwback to a podcast with Joseph Kim, Chief Strategy Officer at ProofPilot, Brad Hightower,...
Over 50% of all FDA warning letters are attributed to non-compliance by the investigator or clinic...